Trial Profile
Effect on Insulin Resistance in Tofogliflozin-treated Japanese Type 2 diabetic patients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 24 Jan 2018
Price :
$35
*
At a glance
- Drugs Tofogliflozin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 19 Jan 2018 Status changed from recruiting to completed.
- 07 Apr 2015 New trial record